We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Mobile Real Time PCR Device Enables COVID-19 Detection in Near-Patient Setting

By LabMedica International staff writers
Posted on 01 Aug 2022

A mobile real time PCR device can expand COVID-19 testing capacity and enable pathogen detection with a multiplex assay at high speed, in addition to offering simplicity of use. More...

Ubiquitome Limited (Auckland, New Zealand) has unveiled its new COVID PCR testing tool named Liberty16 Pro that allows workplaces of up to 500 employees to conduct COVID-testing efficiently with a single, real time PCR device. Surveillance testing at onsite locations can give better early warning, as well as potentially being more cost effective than rapid antigen tests. Liberty16 Pro is an advanced version of Ubiquitome’s Liberty16 mobile real time PCR device which has FDA emergency use authorization for use with the Yale School of Public Health SalivaDirect SARS-CoV-2 assay for diagnostic purposes at certain designated CLIA laboratories.

The Liberty16 mobile PCR system had allowed workplaces to instigate surveillance - checking patients pre-admission, monitoring staff, splitting teams into shifts, and keeping vital supply chain services running. After training by Ubiquitome, many companies and organizations set up dedicated rooms on site and interpret sample results with ease through Ubiquitome's proprietary mobile phone app. Ubiquitome has now developed an advanced version of Liberty16 to expand testing capacity and enable pathogen detection with a multiplex assay and even greater speed - while retaining the existing simplicity of use. The Liberty16 and Liberty16 Pro are research use only devices, not for diagnostic purposes.

"The need for diagnostics that advance clinical care and public health has never been greater with the mutation of Omicron variants picking up speed," said Dr. Paul Pickering, Ubiquitome's CEO. "Developments in the Liberty16 Pro potentially expand testing capacity without sacrificing the assay's detection sensitivity, while further reducing test consumable costs and retaining the unique features which are best fit to a near-patient setting."

Related Links:
Ubiquitome Limited 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Immunofluorescence Analyzer
IFA System
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

Lung cancer is a leading cause of cancer-related death worldwide and is characterized by substantial cellular heterogeneity. Even within a single tumor, cancer cells can vary in aggressiveness, while immune,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.